Active Stocks to Watch: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Qihoo 360 Technology Co. Ltd. (NYSE:QIHU), JinkoSolar Holding Co., Ltd. (NYSE:JKS), Alcoa Inc. (NYSE:AA),

HC Wainwright restated their buy rating on shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) in a research note issued to investors on Thursday morning, Analyst Ratings Net reports. They currently have a $10.00 price objective on the biotechnology company’s stock.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) belongs to Healthcare sector. Its net profit margin is -74.50% and weekly performance is 16.74%. On last trading day company shares ended up at $2.58. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) distance from 50-day simple moving average (SMA50) is 17.48%.

Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) announced that it has called an extraordinary general meeting of shareholders (the “EGM”), to be held on March 30, 2016 at 10:00 a.m. (Beijing time), at 3/F, Building #2, 6 Jiuxianqiao Road, Chaoyang District, Beijing

Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) shares fell -0.29% in last trading session and ended the day at $74.59. QIHU Gross Margin is 77.20% and its return on assets is 8.00%. Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) quarterly performance is 5.53%.

JinkoSolar Holding Co., Ltd. (NYSE:JKS) announced that it has supplied 1MW highly efficient modules to 150 sets off-grid telecom systems in Zambia, creating a precedent in solar energy application.

On 04 March, JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares fell -1.44% and was closed at $23.35. JKS EPS growth in last 5 year was 51.20%. JinkoSolar Holding Co., Ltd. (NYSE:JKS) year to date (YTD) performance is -15.61%.

On 4 March, Alcoa Inc. (NYSE:AA) was recently awarded a five-year contract by the U.S. Army worth up to USD$50 million to develop lightweight, yet durable solutions for ground combat vehicles.

Alcoa Inc. (NYSE:AA) ended the last trading day at $9.57. Company weekly volatility is calculated as 5.01% and price to cash ratio as 6.56. Alcoa Inc. (NYSE:AA) showed a weekly performance of 7.89%.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that Anthony Marucci, Co-founder, President and Chief Executive Officer, will provide a corporate overview at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8, 2016 at 10:00 a.m. EST in Boston.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares fell -0.73% in last trading session and ended the day at $8.19. CLDX return on assets is -34.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -53.78%.

Leave a Reply

Your email address will not be published. Required fields are marked *